These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20228045)

  • 1. Formulation and evaluation of controlled release antibiotic biodegradable implants for post operative site delivery.
    Mathur V; Mudnaik R; Barde L; Roy A; Shivhare U; Bhusari K
    Acta Pharm; 2010 Mar; 60(1):111-7. PubMed ID: 20228045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.
    Bandari S; Eaga CM; Thadishetty A; Yamsani MR
    Acta Pharm; 2010 Mar; 60(1):89-97. PubMed ID: 20228043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards controlled release of BDNF--manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain.
    Koennings S; Sapin A; Blunk T; Menei P; Goepferich A
    J Control Release; 2007 Jun; 119(2):163-72. PubMed ID: 17428570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
    Ali Asghar LF; Azeemuddin M; Jain V; Chandran S
    Drug Deliv; 2009 Aug; 16(6):295-303. PubMed ID: 19606943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembled modules technology for site-specific prolonged delivery of norfloxacin.
    Oliveira PR; Bernardi LS; Strusi OL; Mercuri S; Segatto Silva MA; Colombo P; Sonvico F
    Int J Pharm; 2011 Feb; 405(1-2):90-6. PubMed ID: 21134427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants.
    Elias-Al-Mamun M; Khan HA; Dewan I; Jalil RU
    Pak J Pharm Sci; 2009 Oct; 22(4):360-7. PubMed ID: 19783512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel poly-DL-lactide-polycaprolactone copolymer based flexible drug delivery system for sustained release of ciprofloxacin.
    Waknis V; Jonnalagadda S
    Drug Deliv; 2011 May; 18(4):236-45. PubMed ID: 21189060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.
    Moazeni E; Gilani K; Sotoudegan F; Pardakhty A; Najafabadi AR; Ghalandari R; Fazeli MR; Jamalifar H
    J Microencapsul; 2010; 27(7):618-27. PubMed ID: 20681747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib.
    Shakeel F; Faisal MS
    Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique.
    Pham HH; Luo P; Génin F; Dash AK
    AAPS PharmSciTech; 2002; 3(1):E1. PubMed ID: 12916954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
    Ong HX; Benaouda F; Traini D; Cipolla D; Gonda I; Bebawy M; Forbes B; Young PM
    Eur J Pharm Biopharm; 2014 Jan; 86(1):83-9. PubMed ID: 23851077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
    Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
    Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations.
    Fotaki N; Aivaliotis A; Butler J; Dressman J; Fischbach M; Hempenstall J; Klein S; Reppas C
    Eur J Pharm Biopharm; 2009 Sep; 73(1):115-20. PubMed ID: 19442728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery.
    Doadrio AL; Sousa EM; Doadrio JC; Pérez Pariente J; Izquierdo-Barba I; Vallet-Regí M
    J Control Release; 2004 May; 97(1):125-32. PubMed ID: 15147810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert.
    Mundada AS; Shrikhande BK
    Curr Eye Res; 2008 May; 33(5):469-75. PubMed ID: 18568884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of osmotically controlled oral drug delivery system of glipizide.
    Verma RK; Garg S
    Eur J Pharm Biopharm; 2004 May; 57(3):513-25. PubMed ID: 15093601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a biodegradable antibiotic delivery system.
    Lin SS; Ueng SW; Liu SJ; Chan EC; Chao EK; Tsai CH; Chen KT; Wei FC; Shih CH
    Clin Orthop Relat Res; 1999 May; (362):240-50. PubMed ID: 10335303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casein-based formulations as promising controlled release drug delivery systems.
    Elzoghby AO; El-Fotoh WS; Elgindy NA
    J Control Release; 2011 Aug; 153(3):206-16. PubMed ID: 21338636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.